CAMX ETF holdings (NYSE) | MetaTrader

展开完整图表完整图表

概览所有持仓热图

主要持股 Market Value Shares Weight %

ELV ELEVANCE HEALTH, INC. 3.3018 M 9 550.0000 5.1494%

HON HONEYWELL INTERNATIONAL INCORPORATION 3.2062 M 14.0920 K 5.0003%

UBER UBER TECHNOLOGIES, INC. 3.0739 M 38.4000 K 4.7940%

MDT MEDTRONIC PUBLIC LIMITED COMPANY 2.7143 M 26.3630 K 4.2332%

CME CME GROUP INC. 2.6466 M 9 156.0000 4.1276%

TXN TEXAS INSTRUMENTS INCORPORATED 2.5866 M 12.0000 K 4.0340%

UNP UNION PACIFIC CORPORATION 2.5861 M 11.0000 K 4.0332%

NXPI NXP Semiconductors N.V. 2.5400 M 11.2320 K 3.9613%

BMY BRISTOL-MYERS SQUIBB COMPANY 2.4645 M 44.7680 K 3.8435%

Nintendo Co., Ltd. 2.4432 M 158.6500 K 3.8103%

MAS MASCO CORPORATION 2.4295 M 36.7600 K 3.7889%

A

AMRZ Amrize AG 2.3611 M 44.8700 K 3.6822%

ALGN ALIGN TECHNOLOGY, INC. 2.3186 M 14.2220 K 3.6160%

LH LABCORP HOLDINGS INC. 2.2107 M 8 142.0000 3.4478%

SHIMANO INC. 2.1449 M 188.9800 K 3.3451%

GOOGL ALPHABET INC. 2.1051 M 6 228.0000 3.2830%

ABNB AIRBNB, INC. 2.0597 M 15.9210 K 3.2122%

E

ET ENERGY TRANSFER LP 2.0480 M 111.0000 K 3.1939%

DAL DELTA AIR LINES, INC. 2.0189 M 30.6400 K 3.1486%

DEO DIAGEO PLC 1.8950 M 20.4200 K 2.9553%

1
2

新闻

Camurus第四季度营收不及预期，下调2026年展望

Camurus reports Q4 revenue miss, lowers 2026 outlook

FDA接受Camurus针对肢端肥大症治疗药物Oclaiz的重新申请

FDA accepts Camurus’ resubmission for acromegaly treatment Oclaiz

Camurus 2025年第三季度报告：收入增长18%，但因下调指引股价下跌

Camurus Q3 2025 slides: Revenue up 18% but stock dips on lowered guidance

Camurus下调2025年收入预测，Buvidal销售未达预期

Camurus cuts 2025 revenue forecast as Buvidal sales miss estimates

Camurus 2025年第二季度幻灯片揭示52%的收入激增和关键监管里程碑

Camurus Q2 2025 slides reveal 52% revenue surge and key regulatory milestones

Earnings call transcript: Camurus AB Q2 2025 earnings beat expectations

Camurus Q2 2025 slides: Record revenue and profit amid product portfolio expansion